BioMarin Pharmaceutical revenue and financials
$56.22Change from previous close: −2.29%Absolute change: −$1.32
In the fiscal year ended December 2025, BioMarin Pharmaceutical reported revenue of $3.22B (+12.87% year over year). Net income was $348.9M, a net margin of 10.8%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +12.87%
- 2025 vs 2024
- Net income growth
- −18.26%
- 2025 vs 2024
- Net margin
- 10.8%
- 2024: 15.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 7,594 | 6,989 | 6,842 | 6,375 | 6,003 | 5,848 | 4,690 | 4,427 | 4,633 | 4,024 |
| Current assets | 3,953 | 3,232 | 2,956 | 2,751 | 2,274 | 2,342 | 1,942 | 2,056 | 2,207 | 1,422 |
| Cash and equivalents | 1,312 | 943 | 755 | 725 | 587 | 649 | 437 | 494 | 598 | 408 |
| Short-term investments | 249 | 195 | 319 | 567 | 427 | — | — | — | — | — |
| Receivables | 908 | 661 | 634 | 461 | 373 | — | — | — | — | — |
| Inventory | 1,299 | 1,233 | 1,107 | 894 | 777 | — | — | — | — | — |
| Net property, plant and equipment | 992 | 1,077 | 1,112 | 1,114 | 1,082 | — | — | — | — | — |
| Goodwill | 196 | 196 | 196 | 196 | 196 | 196 | 197 | 197 | 197 | 197 |
| Other intangible assets | 311 | 321 | 325 | 339 | 389 | — | — | — | — | — |
| Long-term investments | 492 | 521 | 622 | 370 | 524 | — | — | — | — | — |
| Current liabilities | 759 | 607 | 1,177 | 589 | 540 | 493 | 933 | 523 | 817 | 439 |
| Accounts payable | 313 | 235 | 316 | 231 | 200 | — | — | — | — | — |
| Long-term debt | 597 | 595 | 593 | 1,083 | 1,079 | — | — | — | — | — |
| Total debt | 606 | 603 | 1,096 | 1,093 | — | — | — | — | — | — |
| Total liabilities | 1,507 | 1,331 | 1,890 | 1,772 | 1,739 | 1,742 | 1,568 | 1,459 | 1,824 | 1,257 |
| Total equity (incl. minority) | 6,087 | 5,658 | 4,952 | 4,603 | 4,266 | — | — | — | — | — |
| Retained earnings | 154 | -195 | -622 | -789 | -931 | — | — | — | — | — |